Stenosis, Internal Carotid Artery Clinical Trial
Official title:
The New Technique of Carotid Endarterectomy With Autoarterial Remodeling of Bifurcation of the Common Carotid Artery.
| NCT number | NCT03027752 |
| Other study ID # | N-RICP-346 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | December 2016 |
| Est. completion date | October 2018 |
| Verified date | August 2016 |
| Source | Meshalkin Research Institute of Pathology of Circulation |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Comparison of two methods for revascularization of the bifurcation of common carotid artery: carotid endarterectomy with longitudinal incision carotid endarterectomy patch angioplasty compared with new technique of carotid endarterectomy with autoarterial remodeling of bifurcation of the common carotid artery
| Status | Completed |
| Enrollment | 200 |
| Est. completion date | October 2018 |
| Est. primary completion date | September 30, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - stenotic lesions of the extracranial part of carotid arteries requiring surgical treatment according to national treatment guidelines (asymptomatic ICA stenosis more than 70% symptomatic ICA stenosis more than 65%) - the length of the atherosclerotic plaques in the ICA than 1 cm - personally signed Informed consent for participation in the study Exclusion Criteria: - Chronic heart failure III-IV functional class NYHA classification - Chronic decompensated "lung" heart - Decompensated diseases of endocrine organs (diabetes glycemia more than 10 mmol/l) - Severe hepatic or renal insufficiency (bilirubin >80 mmol/l, creatinine >200 mmol/l) - Polyvalent drug Allergy; - Malignant tumor in the terminal stage with life expectancy of up to 6 months; - Acute disruption of cerebral blood flow - Extensive occlusion of the internal carotid artery. - Exacerbation of systemic diseases. - Pregnancy and lactation. - The refusal of a patient to sign informed consent for participation in the study |
| Country | Name | City | State |
|---|---|---|---|
| Russian Federation | Novosibirsk Research Institute of Circulation Pathology | Novosibirsk |
| Lead Sponsor | Collaborator |
|---|---|
| Meshalkin Research Institute of Pathology of Circulation |
Russian Federation,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Stroke or TIA | according to the examination of neurologist | throughout 1 year | |
| Secondary | Restenosis | The percentage narrowing of the lumen at the bifurcation of the carotid artery at 1 year after surgery according to the ultrasound | 1 year | |
| Secondary | Restenosis | The percentage narrowing of the lumen at the bifurcation of the carotid artery at 6 months after surgery according to the ultrasound | 6 months | |
| Secondary | paresis of the cranial nerve | Neurological status after surgical treatment according to the examination of neurologist | up to 1 weeks | |
| Secondary | The linear flow velocity in the region of the carotid artery bifurcation | The linear velocity of blood flow in the bifurcation of the carotid artery at 2-3 days after surgery according to the ultrasound | 3rd day | |
| Secondary | The linear flow velocity in the region of the carotid artery bifurcation | The linear velocity of blood flow in the bifurcation of the carotid artery after 6 months according to the ultrasound | 6 months | |
| Secondary | The linear flow velocity in the region of the carotid artery bifurcation | The linear velocity of blood flow in the bifurcation of the carotid artery after 1 year according to the ultrasound | 1 year | |
| Secondary | bleeding | 30 days after surgery | 1 month | |
| Secondary | Stenosis | The percentage narrowing of the lumen at the bifurcation of the carotid artery at 2-3 days after surgery according to the ultrasound | 3rd day | |
| Secondary | Oxygenation of the brain | according to transcranial oximetry | during the surgical intervention | |
| Secondary | Oxygenation of the brain | according to transcranial oximetry | 6 months | |
| Secondary | Oxygenation of the brain | according to transcranial oximetry | 1 year |